High Efficacy of 14-Day Triple Therapy-Based, Bismuth-Containing Quadruple Therapy for Initial Helicobacter pylori Eradication
作者： Qinjuan Sun , Xiao Liang , Qing Zheng , Wenzhong Liu , Shudong Xiao
DOI: 10.1111/J.1523-5378.2010.00758.X
关键词:
摘要: Background: The success rate of currently recommended 7‐day triple therapy with a PPI plus amoxicillin and clarithromycin has fallen into the unacceptable range. It is urgent to look for …
cabdirect.org
sci-hub.se 参考文章(46)
Erik A.J. Rauws, Wies Langenberg, Guido N.J. Tytgat, Hendrik J. Houthoff, H.C. Zanen, Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology. ,vol. 94, pp. 33- 40 ,(1988) , 10.5555/URI:PII:0016508588906063
Alex Ford, Paul Moayyedi, How can the current strategies for Helicobacter pylori eradication therapy be improved Canadian Journal of Gastroenterology & Hepatology. ,vol. 17, ,(2003) , 10.1155/2003/714124
Antona J. Wagstaff, Paul Benfield, Jon P. Monk, Colloidal Bismuth Subcitrate Drugs. ,vol. 36, pp. 132- 157 ,(1988) , 10.2165/00003495-198836020-00002
Marco Romano, Antonio Cuomo, Eradication of Helicobacter pylori: A Clinical Update Medscape general medicine. ,vol. 6, pp. 19- ,(2004)
Giuseppe Scaccianoce, Cesare Hassan, Alba Panarese, Donato Piglionica, Sergio Morini, Angelo Zullo, Helicobacter pylori eradication with either 7-day or 10-day triple therapies, and with a 10-day sequential regimen. Canadian Journal of Gastroenterology & Hepatology. ,vol. 20, pp. 113- 117 ,(2006) , 10.1155/2006/258768
J. P. GISBERT, M. FERNÁNDEZ-BERMEJO, J. MOLINA-INFANTE, B. PÉREZ-GALLARDO, A.-B. PRIETO-BERMEJO, J.-M. MATEOS-RODRÍGUEZ, P. ROBLEDO-ANDRÉS, G. GONZÁLEZ-GARCÍA, First‐line triple therapy with levofloxacin for Helicobacter pylori eradication Alimentary Pharmacology & Therapeutics. ,vol. 26, pp. 495- 500 ,(2007) , 10.1111/J.1365-2036.2007.03384.X
Christopher Rodgers, Sander Veldhuyzen van Zanten, A meta-analysis of the success rate of Helicobacter pylori therapy in Canada. Canadian Journal of Gastroenterology & Hepatology. ,vol. 21, pp. 295- 300 ,(2007) , 10.1155/2007/419784
P Malfertheiner, F Megraud, C O'morain, D Bell, Bianchi G Porro, M Deltenre, D Forman, G Gasbarrini, B Jaup, JJ Misiewicz, J Pajares, M Quina, E Rauws, European Helicobacter pylori Study Group, None, Current European concepts in the management of Helicobacter pylori infection the Maastricht Consensus Report European Journal of Gastroenterology & Hepatology. ,vol. 9, pp. 1- 2 ,(1997) , 10.1097/00042737-199701000-00002
Anita Paula Ortiz Godoy, Marcelo Lima Ribeiro, Yune Helena Borges Benvengo, Lea Vitiello, Maira de Carvalho Bueno Miranda, Sergio Mendonça, José Pedrazzoli, Analysis of antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates BMC Gastroenterology. ,vol. 3, pp. 20- 20 ,(2003) , 10.1186/1471-230X-3-20
Pedro Carpintero, Margarita Blanco, Jose Maria Pajares, Ranitidine Versus Colloidal Bismuth Subcitrate in Combination with Amoxicillin and Metronidazole for Eradicating Helicobacter pylori in Patients with Duodenal Ulcer Clinical Infectious Diseases. ,vol. 25, pp. 1032- 1037 ,(1997) , 10.1086/516084